Capsule Summary Slidesets

Share

Program Content

Activities

  • TRIBE2 Updated Analysis
    Updated Analysis of Phase III TRIBE2: FOLFOXIRI + Bev → FOLFOXIRI + Bev vs FOLFOX + Bev → FOLFIRI + Bev in Unresectable Metastatic Colorectal Cancer
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 02, 2019

    Expires: May 31, 2020

  • APACT
    Phase III APACT Trial: Adjuvant nab-Paclitaxel Plus Gemcitabine vs Gemcitabine in Patients With Surgically Resected Pancreatic Adenocarcinoma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 04, 2019

    Expires: June 02, 2020

  • KEYNOTE-240
    Phase III KEYNOTE-240: Second-line Treatment With Pembrolizumab + BSC vs Placebo + BSC in Advanced Hepatocellular Carcinoma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 04, 2019

    Expires: June 02, 2020

  • TAGS: Subset Analyses/HRQoL
    Subgroup Analyses and Overall HRQoL From Phase III TAGS: Trifluridine/Tipiracil vs Placebo in Previously Treated Gastric/GEJ Adenocarcinoma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 11, 2019

    Expires: June 09, 2020

  • NAVIGATOR
    Phase I NAVIGATOR Trial of Avapritinib in Patients With Metastatic GIST Harboring PDGFRA Exon 18 Mutations or as Fourth-line or Higher Therapy
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 05, 2019

    Expires: June 03, 2020

  • Phase III POLO Trial
    POLO: Randomized, Placebo-Controlled Phase III Trial of Maintenance Olaparib in Patients With Metastatic Pancreatic Cancer and Germline BRCA Mutation
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 06, 2019

    Expires: June 04, 2020

Provided by

ProCE Banner

Supporters

Amgen, Inc.

Astellas Seattle Genetics

Bayer Healthcare Pharma

Blueprint Medicines

Celgene

Novartis Pharmaceuticals Corporation

Puma Biotechnology, Inc.

Taiho Oncology Inc

Tesaro